PCSK9 inhibitors have unexpected anti-inflammatory effects
PCSK9 inhibition is a new therapeutic strategy for atherosclerosis which is known to lower LDL cholesterol. Research from Karolinska Institutet, presented at the ESC Congress last year and now published in the Journal of ...
Apr 6, 2018
0
4